Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, originally known as OMP-131R10, represents a unique monoclonal antibody developed to inhibit granulocyte-macrophage colony-stimulating GM-CSF. Its process of https://www.targetmol.com/compound/rosmantuzumab